ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
119.662,38
0,08%
S&P 500
5.431,60
-0,04%
US Dollar vs BRL
5,3773
0,01%
Bitcoin
66.105,02
0,15%
Brent Oil
82,275
0,00%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. Reino Unido
  5. LSE
  6. Gsk Plc (GSK)

  7. Gsk Plc (GSK) Notícias

GSK

Gsk (GSK)

Gsk Plc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:LSE:GSK
DataHoraFonteTítuloCódigoCompanhia
12/06/202411:30RNS Regulatory NewsGSK PLC Director/PDMR ShareholdingLSE:GSKGsk Plc
11/06/202405:32Alliance NewsAlliance NewsTOP NEWS: GSK takes first steps to appeal Zantac ruling in DelawareLSE:GSKGsk Plc
11/06/202403:00RNS Regulatory NewsGSK PLC Statement: Zantac (ranitidine) litigationLSE:GSKGsk Plc
10/06/202415:00Alliance NewsAlliance NewsTOP NEWS: GSK welcomes dismissal of Zantac case in IllinoisLSE:GSKGsk Plc
10/06/202404:39Alliance NewsAlliance NewsGSK gets FDA approval for Arexvy vax in 50-59 year olds at risk of RSVLSE:GSKGsk Plc
10/06/202403:00RNS Regulatory NewsGSK PLC FDA approves Arexvy for adults 50-59 at riskLSE:GSKGsk Plc
03/06/202411:00RNS Regulatory NewsGSK PLC Total Voting RightsLSE:GSKGsk Plc
03/06/202410:01Alliance NewsAlliance NewsGSK immunotherapy bowel cancer drug works for 100% of patientsLSE:GSKGsk Plc
03/06/202409:03RNS Regulatory NewsGSK PLC Unprecedented results in Jemperli trial continueLSE:GSKGsk Plc
03/06/202405:08Alliance NewsAlliance NewsTOP NEWS: GSK vows to appeal adverse Delaware court ruling on ZantacLSE:GSKGsk Plc
03/06/202403:05RNS Regulatory NewsGSK PLC ASCO positive Blenrep DREAMM-8 trial resultsLSE:GSKGsk Plc
24/05/202404:36Alliance NewsAlliance NewsTOP NEWS: GSK celebrates Illinois jury verdict in Valadez caseLSE:GSKGsk Plc
21/05/202404:49Alliance NewsAlliance NewsGSK's depemokimab asthma treatment meets endpoints in latest trialsLSE:GSKGsk Plc
21/05/202403:00RNS Regulatory NewsGSK PLC Positive phase III asthma results for depemokimabLSE:GSKGsk Plc
20/05/202412:11Alliance NewsAlliance NewsIN BRIEF: GSK executive buys GBP20,026 worth sharesLSE:GSKGsk Plc
17/05/202405:03Alliance NewsAlliance NewsTOP NEWS: GSK sells remaining Haleon stake for GBP1.25 billionLSE:GSKGsk Plc
17/05/202403:00RNS Regulatory NewsGSK PLC GSK completes sale of shares in Haleon plcLSE:GSKGsk Plc
16/05/202413:13Alliance NewsAlliance NewsTOP NEWS: GSK to sell remaining holding in spin-off HaleonLSE:GSKGsk Plc
16/05/202412:42RNS Regulatory NewsGSK PLC GSK announces intention to sell shares in HaleonLSE:GSKGsk Plc
13/05/202411:00RNS Regulatory NewsGSK PLC Block listing Interim ReviewLSE:GSKGsk Plc
08/05/202414:21RNS Regulatory NewsGSK PLC Result of AGMLSE:GSKGsk Plc
08/05/202412:57RNS Regulatory NewsGSK PLC Board Committee ChangeLSE:GSKGsk Plc
01/05/202404:50Alliance NewsAlliance NewsTOP NEWS: GSK expects momentum to continue after strong first quarterLSE:GSKGsk Plc
01/05/202403:00RNS Regulatory NewsGSK PLC 1st Quarter ResultsLSE:GSKGsk Plc
24/04/202405:14Alliance NewsAlliance NewsGSK's Jemperli with chemotherapy accepted for priority review by FDALSE:GSKGsk Plc
24/04/202403:00RNS Regulatory NewsGSK PLC US FDA accepts new indication filing for JemperliLSE:GSKGsk Plc
17/04/202404:46Alliance NewsAlliance NewsTOP NEWS: GSK hails data on Shingles vaccine and gonorrhoea treatmentLSE:GSKGsk Plc
17/04/202403:05RNS Regulatory NewsGSK PLC GSK announces additional EAGLE-1 resultsLSE:GSKGsk Plc
17/04/202403:00RNS Regulatory NewsGSK PLC Results from long-term data relating to ShingrixLSE:GSKGsk Plc
16/04/202410:11RNS Regulatory NewsGSK PLC Amendment - Director/PDMR ShareholdingLSE:GSKGsk Plc
 Apresentando as notícias mais relevantes sobre:LSE:GSK

Seu Histórico Recente

LSE
0P3K
Dedicare Ab (publ)
NYSE
BRBR
BellRing Brands
KUCN
FITFIUSDT
STEP.APP
CSE
DIXI.U
Dixie Brands
LSE
61QU
Cred Ag Co.25
BIT
P1YYR5
NLBNPIT1YYR5 20991231 4....
LATK
ETHOSBTC
COIN
MTCEUR
Medical Token Currency
USOTC
LXRBF
Luxor AS (GM)
AQSE
BIOM.GB
Biome Technologies
BIT
P17XS1
BNP Paribas Issuance
COIN
CGPBTC
NASDAQI
ZIRTR
ISE Junior Silver Miners...
ASX
NTI
Neurotech
NASDAQ
UTVAX
ShortTerm InvestmentGrad...
BIT
P1QZZ1
BNP Paribas Issuance
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados